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To assess quantitatively the association between benzene and leukemia, we evaluated the rate ofmortal-
ity experienced by a cohort occupationally exposed to benzene. Using data from historical airsampling sur-
veys, we estimated the daily benzene exposure foreach member ofthe cohort. The expected number ofleuke-
mia deaths was calculated andcompared tothe actual number ofleukemia deathsthat occurred. The overall
standardized mortality ratio (SMR) forleukemia was 337. Person-years atriskwithinthecohort were stratified
by increasing levels ofcumulative benzene exposure. The resulting SMRs increased from 109 to 322 to 1186
and to 6637 with respective increases in cumulative benzene exposure from less than 40ppm-years to40-199,
200-399, and greaterthan 400. The shape ofthe exposure-response relation wasexamined with acase-control
analysis. Another analysis wasperformed to take into account an induction period for leukemia. All ofthe
analyses demonstrated that a strongly positive exposure-response relationship etists between benzene and
leukemia. Previous attempts to quantify this cohort's risk ofdeveloping leukemia were based on surrogates
ofexposure, such as duration ofemployment. Usingactual airsamplingdata to estimate individual exposures
represents a marked improvement over these previous attempts andemphasizes the importance ofconduct-
ing industrial hygiene surveys and maintaining historical exposure records.
The etiologic association between benzene and leuke-
mia has been firmly established by clinical observations,
epidemiologic studies, and by carcinogenesis bioassays
(1-14). However, largely because of the 1980 Supreme
Court decision requiring OSHA to demonstrate "signif-
icant risk ofmaterial health impairment" at a given level
ofbenzene exposure, the settingofan exposure standard
became dependent upon estimates of the exposure-
response relationship. The efficacy ofsuch a risk assess-
ment based on epidemiologic observation is conditional
on the validity ofthe estimates ofexposure forthe popu-
lation under study.
In 1987, NIOSH published the results ofa risk assess-
ment ofbenzene and leukemia based on a cohort ofrub-
ber workers occupationally exposed to benzene during
the manufacturing of rubber hydrochloride (15). This
same cohort had been studied earlier and the resulting
qualitative causal associationbetweenbenzene andleuke-
miareported. Although theexperiences ofotherbenzene-
exposed populations has been studied, this cohort was
unique by virtue ofits combination of size, the relative
purity of exposure, and the exceptional record system
that existed chr'onicling the changes in measured area
benzene concentrations over35years ofoperations. This
record system allowed thereconstruction ofabenzene ex-
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posure history profile not dependent onperception orre-
call specific for each individual worker in the cohort. It
is this exposure profile that gives this study the advan-
tage in defining the exposure-response relationship.
The concept behind the development of the NIOSH
benzene riskassessment was straightforward; ifthe daily
amount ofexposure to benzene an individual received at
theirjob couldbe estimatedthenthe individual's cumula-
tive amount ofexposure couldbe calculated for any time
intheirpast. Person-years at-risk couldthenbe stratified
by actual cumulative exposure, andrelative risk couldbe
calculatedforeach category ofincreasingexposure. This
would be a major improvement over previous attempts
at quantitating the exposure-response relationship that
hadbeenused inprevious analyses ofthis cohort. These
previous attempts used surrogates ofexposure, such as
duration ofemployment, which were inherently less ac-
curate because they failed to take into account different
intensities of exposure resulting from differences be-
tweenjobs, changes in production levels and engineering
improvements over time.
Development ofan exposure matrix was central to the
process ofdetermining the personal exposure history of
an individual worker. The exposure matrix had to take
into account the individual's specific job as well as the
time period in which thatjob was beingperformed. For
every individual in the cohort apersonnel folder existed
that very accurately chronicled theirjob history by list-R. A. RINSKY
ing the department code, a job title, and the date that
specific job operations began and ended. The rubber
hydrochloride department under study operated at two
differentgeographical locations. Unusually complete and
extensive historical industrial hygiene measurements for
one of these locations were available from a number of
sources including company records, Ohio Department of
Health records, Ohio Industrial Commission records,
from asurvey conducted bythe University ofNorth Car-
olina, andfinally from a survey conducted by NIOSH in
the course ofstudyingthis cohort. These historical indus-
trial hygiene data were primarily area samples rather
than personal samples. The exposure matrix was com-
posedbygroupingactualjobs into exposure classesbased
on the areas in which the job was performed.
Ten exposure classes were eventually defined. Foreach
yearfrom 1939 to 1976, the annual mean ofthe measured
benzene concentrations was tabulated into the appropri-
ate exposure class by year cell in the matrix. In years
where no historical environmental data existed, interpo-
lation was made between the values forthe years where
such measurements did exist or, in those years where
there was no earlier (or later) measurement, the most
proximate value was projected back(orforward). Indus-
trial hygiene measurements were sparse atthe secondlo-
cationbut theprocesses andjob assignments were essen-
tially identical. Benzene exposure levels measured at the
firstlocation were assumed as naturally occurring simu-
lations ofexposure levels in corresponding areas at the
secondlocation. The completed exposure matrixprovided
a reference to estimate the daily exposure experienced
by each individual in the cohort.
The rate ofleukemia mortality experienced bythis co-
hort was determined by using the NIOSH Life-Table
Analysis System togenerate expected numbers ofcause-
specific deaths, within 5-year age and 5-year calendar
time periods (16). These calculations were based on
United States white male death rates speciflc for the
same 5-year age andcalendartimeperiods, applied tothe
number of person-years at-risk of dying. Person-years
were further stratified by cumulative benzene exposure
and by 5-year latency periods (interval since initial ex-
posure). To determine cumulative benzene exposure, an
individual's daily benzene exposure was obtained from
the appropriate cell in the exposure-class/year matrix.
Exposures were then accumulated by summation ofthe
daily values over a individual's entire working career.
The cohort was divided into four categories ofexposure.
These exposure stratawere 1 ppm dayto39partpermil-
lion years (ppm-years), 40 to 199 ppm-years, 200 to 399
ppm-years, and more than 400ppm-years. These bound-
aries correspond to the cumulative exposure thatwould
result from average annual exposures to less than 1, 1 to
5, 5 to 10, and 10 or more parts per million benzene,
respectively, accumulated over a 40-year working life-
time. Observed numbers of deaths for each cause were
divided by the expected to obtain cause-specific stan-
dardized mortality ratios (SMRs).
Additionally, to identify the functional form of the
exposure-response relationship, a matched case-control
analysis wasperformedusingconditional logistic regres-
sion. Ten controls were matched to eachleukemia death
by year ofbirth and yearfirst employed. These controls
were selected from among those cohort members still
alive at the time ofdeath ofthe corresponding case. Be-
cause the case-control analysisuses aninternal control(as
opposed to the U.S. general populationused as the refer-
entgroupin the SMR analysis), it has the additional ben-
efit ofcontrolling for other exposures as well as any ad-
ditional background exposure to benzene that may have
been present.
A statistically significant increase in deaths from all
lymphatic and hematopoietic neoplasms was observed.
(There were 15 observed deaths versus 6.6 expected,
SMR = 227.)Thisincreasewas duemainlyto excessnum-
bers ofdeaths from leukemia (9 observed versus 2.7 ex-
pected, SMR = 337, CI = 154-641) and from multiple
myeloma(4 observed versus 1 expected, SMR = 409, CI
= 110-1047). SMRsforleukemia, overthe fourexposure
strata demonstrated a marked, progressive increase with
increasingexposure to benzene (SMRs = 109,322, 1186,
and 6637). No apparent pattern was evident for these
deathswith regard to latency, whichranged from under
5 to over 30 years.
SMRsformultiplemyeloma, overthe four original ex-
posure strata, did not increase with increasing exposure.
Three ofthe four myeloma cases had less than 40 ppm-
years exposure (based upon ourassumptions ofdose), and
all four occurred after 20 years of latency. All four of
these deaths were from the same location.
Usingthe case-control analysis, we determinedthatthe
equationbest describingthe oddsratioforleukemiain re-
lation to cumulative exposure to benzene was
OR = exp (0.0126 x ppm-years)
(CI = 0.0028-0.0224, x2 = 6.4, p = 0.011). Totake into ac-
count an induction period for leukemia, benzene ex-
posures occurring within the 5-year period prior to the
death of a case were eliminated from the calculated cu-
mulative exposure. The odds ratios increased slightly as
did the statistical signiflcance of the observation.
The major findings of this analysis were: a) that a
strongly positive exposure-response relationship exists
between benzene and leukemia; b) that, based upon the
model, this relationship extends downward to mean an-
nual exposure levels ofless than 1 ppm, cumulated over
a 40-year working lifetime; and c) that there also exists
in thepopulation studied a statistically significant excess
of deaths from multiple myeloma.
Because the environmental data used in this risk as-
sessmentwere collectedforreasonsotherthan to support
epidemiologic study, they are not complete. Measured en-
vironmental levels did not exist for all years and had to
be constructed from extant data. In some cases this
meant allowing a single measured exposure to serve for
anumber ofyears. Episodes ofhigh exposure because of
such temporary circumstances as spills and process up-
sets were probably overlookedby the industrial hygiene
surveys. In addition, percutaneous absorption ofbenzene,
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a route ofexposure that has been shown to be ofpoten-
tial importance, was not examined. Nevertheless, the ex-
isting environmental data are unusually comprehensive
in comparison to those typically available for retrospec-
tive cohort studies. They permit a reasonable estimate
of cumulative benzene exposure during rubber hydro-
chloride production for each member ofthis study popu-
lation. Ifthe environmental data are in error, webelieve
they likely err by overestimating actual average ex-
posures, for two reasons. First, the majority ofthe mea-
surements were taken byindustrial hygienistslookingfor
trouble spots within the process rather than trying to
document typical personal exposures. Second, the eco-
nomic viability ofthe rubber hydrochloride manufactur-
ing process depended upon efficient recovery of costly
solvent; indeed, much of the process was dedicated to-
ward this end. Continuous high-level contamination by
benzene of a large ventilated area would not have been
economically acceptable.
Periodicallywe intend toupdate this analysis by follow-
ingup on the mortality experience ofthe cohort. Subse-
quent to these analyses presented we learned ofthe oc-
currence of another leukemia death among the cohort.
Ten additional controls were chosen and the case-control
analysis was repeated. This resulted in slightly lower
odds ratio but increased the statistical significance ofthe
relationship. The data from this additional case serves as
additional corroborating evidence.
Multiple myeloma, whichwasthe cause ofdeathinfour
members ofthis cohort, has been observedpreviously in
persons exposed to benzene(17). In addition, several re-
cent toxicologic studies have demonstrated lymphoid
malignancies in both rats and mice exposed to benzene
(18-21). Itis ofinterest that three ofthefour deaths from
multiple myeloma that were observed in this cohort oc-
curred among the group with the lowest cumulative ex-
posure tobenzene(< 40ppm-years), andthat all fourre-
quiredexceptionally longlatencyperiodsforhematologic
malignancies (> 20years). These two observations raise
thepossibility thatlow cumulative exposures to benzene
mayproduce a relatively well-differentiated malignancy
suchasmultiplemyeloma, whereashigherexposureslead
to leukemia. In this construct, it is conceivable that the
progressive reduction ofexposures tobenzene, which has
been achieved over the last several decades, may lead to
a situation in which multiple myeloma will in the future
become manifest in a large population of workers with
relatively low cumulative exposures to benzene. The
present observations must, however, be interpreted cau-
tiously in absence of further corroborations.
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